Top Stories

Mylan delays merger with Upjohn due to COVID-19 pandemic

PITTSBURGH — The Mylan NV-Upjohn merger is being pushed back into the second half of 2020 due to the COVID-19 global pandemic.

Mylan NV (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE), which owns Upjohn, announced Thursday that COVID-19 is moving the expected merger date from the first half of the year and Mylan’s meeting of shareholders to approve it is being moved from April 27 to June 30.

Read more in the Pittsburgh Business Times.